Hector M Garcia - JoVE Visualize

Showing results (321-330 of 466) with videos related to

Pageof 47

Sort By:

Journal of Clinical Medicine|September 28, 2023

First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP StudyAnna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.

The International Journal of Cardiovascular Imaging|May 16, 2020

Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarctionGiovanni Luigi De Maria, Roberto Scarsini, Mayooran Shanmuganathan, et al.

European Heart Journal|May 23, 2017

Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-upAnne-Sophie Schuurman, Maxime Vroegindewey, Isabella Kardys, et al.

Circulation|January 15, 2016

Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence TomographyMasanori Taniwaki, Maria D Radu, Serge Zaugg, et al.

JACC. Cardiovascular Imaging|March 17, 2012

Natural history of coronary atherosclerosis by multislice computed tomographyStella-Lida Papadopoulou, Lisan A Neefjes, Hector M Garcia-Garcia, et al.

Lancet (London, England)|September 19, 2014

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialPatrick W Serruys, Bernard Chevalier, Dariusz Dudek, et al.

Journal of Clinical Medicine|April 9, 2024

Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807Anna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2014

Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiographyJin M Cheng, K Martijn Akkerhuis, Olivier Meilhac, et al.

European Heart Journal. Cardiovascular Imaging|July 19, 2018

Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progressionChristos V Bourantas, Anantharaman Ramasamy, Alexios Karagiannis, et al.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.

Pageof 47

Showing results (321-330 of 466) with videos related to

Sort By:

Pageof 47

Journal of Clinical Medicine|September 28, 2023

First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP StudyAnna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.

The International Journal of Cardiovascular Imaging|May 16, 2020

Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarctionGiovanni Luigi De Maria, Roberto Scarsini, Mayooran Shanmuganathan, et al.

European Heart Journal|May 23, 2017

Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-upAnne-Sophie Schuurman, Maxime Vroegindewey, Isabella Kardys, et al.

Circulation|January 15, 2016

Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence TomographyMasanori Taniwaki, Maria D Radu, Serge Zaugg, et al.

JACC. Cardiovascular Imaging|March 17, 2012

Natural history of coronary atherosclerosis by multislice computed tomographyStella-Lida Papadopoulou, Lisan A Neefjes, Hector M Garcia-Garcia, et al.

Lancet (London, England)|September 19, 2014

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialPatrick W Serruys, Bernard Chevalier, Dariusz Dudek, et al.

Journal of Clinical Medicine|April 9, 2024

Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807Anna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2014

Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiographyJin M Cheng, K Martijn Akkerhuis, Olivier Meilhac, et al.

European Heart Journal. Cardiovascular Imaging|July 19, 2018

Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progressionChristos V Bourantas, Anantharaman Ramasamy, Alexios Karagiannis, et al.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.

Pageof 47